Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.

Yingjie BianZheng ZhangZhichen SunJuanjuan ZhaoDanming ZhuYang WangSherry FuJingya GuoLongchao LiuLishan SuFu-Sheng WangYang-Xin FuHua Peng

Published in: Hepatology (Baltimore, Md.) (2017)

These results suggest that preS1 can function as a therapeutic vaccine for the control of CHB. (Hepatology 2017;66:1067-1082).

Keyphrases